Medicollect’s competences on recruiting people with diabetes for clinical trials have been in great demand.
Based on clients’ requests Medicollect has decided to add Neurology as a core recruitment service. In UK Medicollect already has a client, Canbex Therapeutics, who is dedicated to treating spasticity in multiple sclerosis.
The company CEO, Torben Lind agrees that it is a bold move:
“It’s clearly a very ambitious strategy to expand that quickly, but we have set the pace high because our clients are happy with our services. We are looking forward to working on other MS projects as well as projects focusing on Alzheimer’s and Parkinson. “
So far, companies such as Novartis, GSK, and the international CRO, Pharm-Olam, have shown interest in using Medicollect’s recruitment services within neurology as well.